Kurosumi M - Search Results

1

The efficacy and limitations of repeated slide conferences for improving interobserver agreement when judging nuclear atypia of breast cancer. The Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) Pathology Section.

Tsuda H, Akiyama F, Kurosumi M, Sakamoto G, Watanabe T. Tsuda H, et al. Among authors: kurosumi m. Jpn J Clin Oncol. 1999 Feb;29(2):68-73. doi: 10.1093/jjco/29.2.68. Jpn J Clin Oncol. 1999. PMID: 10089946

2

Establishment of histological criteria for high-risk node-negative breast carcinoma for a multi-institutional randomized clinical trial of adjuvant therapy. Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) Pathology Section.

Tsuda H, Akiyama F, Kurosumi M, Sakamoto G, Watanabe T. Tsuda H, et al. Among authors: kurosumi m. Jpn J Clin Oncol. 1998 Aug;28(8):486-91. doi: 10.1093/jjco/28.8.486. Jpn J Clin Oncol. 1998. PMID: 9769782 Clinical Trial.

3

Monitoring of interobserver agreement in nuclear atypia scoring of node-negative breast carcinomas judged at individual collaborating hospitals in the National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) protocol.

Tsuda H, Akiyama F, Kurosumi M, Sakamoto G, Watanabe T. Tsuda H, et al. Among authors: kurosumi m. Jpn J Clin Oncol. 1999 Sep;29(9):413-20. doi: 10.1093/jjco/29.9.413. Jpn J Clin Oncol. 1999. PMID: 10563193

4

A quantitative model using mean and standard deviation for evaluation of interobserver agreement in nuclear atypia scoring of breast carcinomas in a protocol study.

Tsuda H, Akiyama F, Kurosumi M, Sakamoto G, Watanabe T. Tsuda H, et al. Among authors: kurosumi m. Pathol Int. 2000 Feb;50(2):119-25. doi: 10.1046/j.1440-1827.2000.01017.x. Pathol Int. 2000. PMID: 10792770

5

Evaluation of the interobserver agreement in the number of mitotic figures of breast carcinoma as simulation of quality monitoring in the Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) protocol.

Tsuda H, Akiyama F, Kurosumi M, Sakamoto G, Yamashiro K, Oyama T, Hasebe T, Kameyama K, Hasegawa T, Umemura S, Honma K, Ozawa T, Sasaki K, Morino H, Ohsumi S. Tsuda H, et al. Among authors: kurosumi m. Jpn J Cancer Res. 2000 Apr;91(4):451-7. doi: 10.1111/j.1349-7006.2000.tb00966.x. Jpn J Cancer Res. 2000. PMID: 10804295 Free PMC article.

6

A proposal for the histopathological diagnosis of ductal carcinoma in situ of the breast.

Moriya T, Kasami M, Akiyama F, Ichihara S, Kurosumi M, Tsuda H, Umemura S, Akashi-Tanaka S, Imamura H, Iwase H, Shin E, Harada Y, Mitsuyama S, Ohuchi N. Moriya T, et al. Among authors: kurosumi m. Breast Cancer. 2000;7(4):321-5. doi: 10.1007/BF02966398. Breast Cancer. 2000. PMID: 11114858

7

Histopathological criteria for assessment of therapeutic response in breast cancer.

Kurosumi M, Akiyama F, Iwase T, Motomura K, Okazaki M, Tsuda H; Commitee for Production of Histopathological Criteria, Japanese Breast Cancer Society. Kurosumi M, et al. Breast Cancer. 2001;8(1):1-2. doi: 10.1007/BF02967471. Breast Cancer. 2001. PMID: 11180759 No abstract available.

8

Detection of HER-2/neu (c-erb B-2) DNA amplification in primary breast carcinoma. Interobserver reproducibility and correlation with immunohistochemical HER-2 overexpression.

Tsuda H, Akiyama F, Terasaki H, Hasegawa T, Kurosumi M, Shimadzu M, Yamamori S, Sakamoto G. Tsuda H, et al. Among authors: kurosumi m. Cancer. 2001 Dec 15;92(12):2965-74. doi: 10.1002/1097-0142(20011215)92:12<2965::aid-cncr10156>3.0.co;2-a. Cancer. 2001. PMID: 11753973 Clinical Trial.

9

Evaluation of HER2 status: for the treatment of metastatic breast cancers by humanized anti-HER2 Monoclonal antibody (trastuzumab) (Pathological committee for optimal use of trastuzumab).

Umemura S, Sakamoto G, Sasano H, Tsuda H, Akiyama F, Kurosumi M, Tokuda Y, Watanabe T, Toi M, Hasegawa T, Osamura RY. Umemura S, et al. Among authors: kurosumi m. Breast Cancer. 2001;8(4):316-20. doi: 10.1007/BF02967531. Breast Cancer. 2001. PMID: 11791124 Review.

10

Evaluation of interobserver agreement in scoring immunohistochemical results of HER-2/neu (c-erbB-2) expression detected by HercepTest, Nichirei polyclonal antibody, CB11 and TAB250 in breast carcinoma.

Tsuda H, Sasano H, Akiyama F, Kurosumi M, Hasegawa T, Osamura RY, Sakamoto G. Tsuda H, et al. Among authors: kurosumi m. Pathol Int. 2002 Feb;52(2):126-34. doi: 10.1046/j.1440-1827.2002.01327.x. Pathol Int. 2002. PMID: 11940217

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters